Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

{{ error }}

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Please Try Again

{{ error }}

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

or

Privacy Policy | Disclaimer

Quote | Bullboard | News | Opinion | Profile | Peers | Filings | Financials | Options | Price History | Ratios | Ownership | Insiders | Valuation

Liminal BioSciences Inc. PFSCF

Primary Symbol: LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc.

Bullboard Posts

Post by DryBoneson Oct 01, 2015 6:05pm

227 Views

Post# 24155113

HOW MANY PATIENTS REQUIRED

How many patients required...

https://www.ncbi.nlm.nih.gov/pubmed/15784083

Clinical trials : how many patients are required to achieve statistically significant results?

Abstract

SO THE SHORT ANSWER IS; THE BETTER THE RESULTS OF THE DRUG TESTED,THE FEWER PATIENTS NEEDED IN THE CLINICAL TRIAL.

Bullboard Posts

Pro Women’s Hockey League comes to NHL 25 in December

Pro Women’s Hockey League comes to NHL 25 in December

From now on, dynaCERT instead of Bitcoin or NVIDIA?

From now on, dynaCERT instead of Bitcoin or NVIDIA?

Bombardier delivers Global 6500 aircraft to U.S. Army

Bombardier delivers Global 6500 aircraft to U.S. Army

Changing Europe’s dependency on HREE from China

Changing Europe’s dependency on HREE from China

FE Battery Metals begins 2024 winter drill program

FE Battery Metals begins 2024 winter drill program